Margrave David R.

Margrave David R. is listed in filings as Chief Financial Officer at Lantern Pharma Inc.. This profile follows SEC Form 4 activity through Dec 22, 2025, including 2 public disclosures. Recent filings connect the profile to Lantern Pharma Inc. (LTRN). The current snapshot covers public activity from Jul 17, 2024 to Dec 22, 2025. Reported amounts are shown as $64.8K to $226.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.